Sarepta Therapeutics, Inc. 13D and 13G filings for Arrowhead Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-14 5:23 pm Purchase |
2025-02-07 | 13D | Arrowhead Pharmaceuticals, Inc. ARWR |
Sarepta Therapeutics Inc. SRPT |
11,926,301 9.500% |
11,926,301 (New Position) |
Filing |